What are the Top Growth Segments in U.S. Soft Tissue Repair (2025)?
The U.S. orthopedic soft tissue repair market is valued at over $2.3 billion in 2024 and projected to reach nearly $3.4 billion by 2031.
While rotator cuff repair continues to dominate, other segments like hip arthroscopy and ACL reconstruction are capturing attention with faster expansion rates.
Competitive pressures are intensifying as new fixation systems and ASC-optimized kits reshape the landscape.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ U.S. Soft Tissue Repair Market Painpoints and Growth Opportunities
➜ Why Rotator Cuff Repair Still Leads the Market
➜ How Hip Arthroscopy Became the Fastest-Growing Segment
➜ ACL/PCL Reconstruction’s Competitive Momentum
➜ How to Apply These U.S. Soft Tissue Repair Market Insights to Market Strategy
Key Takeaways
- The U.S. orthopedic soft tissue repair market is growing 5.6% annually, reaching $3.4 billion by 2031.
- Rotator cuff repair remains the largest contributor, driven by advanced fixation and ASC integration.
- Hip arthroscopy is the fastest-growing segment due to technique refinement and outpatient adoption.
- ACL/PCL reconstruction growth is fueled by innovation in fixation and standardized surgical approaches.
- Pricing pressure and ASC-focused contracts are challenging premium product margins.
U.S. Soft Tissue Repair Market Painpoints and Growth Opportunities
📌 Learn More About the U.S. Soft Tissue Repair Market:
Price competition continues to limit premium product expansion, especially as ASC-focused contracts emphasize cost efficiency over differentiation.
Despite this, procedure growth remains the strongest driver of market value, supported by an aging population, sports participation, and improved recovery protocols.
Three key figures illustrate the shift:
- $2.3 billion (2024) market baseline expanding to $3.4 billion by 2031.
- 5.6% CAGR, signaling robust long-term momentum.
- Hip arthroscopy leading segment growth with rates above the market average.
Opportunities center around devices that streamline ASC workflows, enhance fixation reproducibility, and enable tissue preservation.
Segments tied to these benefits, like hip arthroscopy and ACL reconstruction, are expected to outperform over the forecast period.
Why Rotator Cuff Repair Still Leads the Market
Rotator cuff repair remains the largest and most established segment, backed by strong clinical evidence and high surgical volumes.
The adoption of knotless and all-suture anchors continues to simplify shoulder arthroscopy and reduce OR time. Manufacturers are competing to refine instrument sets designed for ambulatory centers, where cost and efficiency are key.
However, growth has moderated compared to emerging areas.
The segment’s maturity and stable pricing environment limit upside, but its scale and procedural consistency ensure ongoing leadership within orthopedic soft tissue repair.
How Hip Arthroscopy Became the Fastest-Growing Segment
Once a niche procedure, hip arthroscopy has rapidly gained ground as the fastest-growing category in 2024.
Advances in portal access systems, RF probes, and closure technologies have reduced complexity and improved consistency. Broader adoption across ASCs and hospital outpatient centers is accelerating volumes.
Manufacturers offering comprehensive systems that integrate visualization, fixation, and capsular management are gaining traction.
The segment’s rise reflects a clear shift toward minimally invasive, reproducible procedures suited for outpatient settings, driving its growth well above the market average.
Recent U.S. claims data show hip arthroscopy cases nearly doubled from 2015 to 2023, with incidence projected to keep rising through 2030, reinforcing the above-market growth outlook.
ACL/PCL Reconstruction’s Competitive Momentum
ACL/PCL reconstruction ranks third in total value and second in growth rate.
Increased use of pre-sutured and pre-sized allografts, along with biocomposite and adjustable-loop fixation, supports more predictable results and faster recovery.
The market benefits from steady sports injury volumes and improved standardization among surgeons and athletic organizations.
While competition remains intense, companies focusing on surgical efficiency and reproducible outcomes are strengthening their positions.
Evidence syntheses also document the widespread use and comparable performance of adjustable-loop cortical button fixation versus alternatives, supporting the segment’s shift toward standardized, reproducible constructs.
As these products align with evolving ASC workflows, this segment is expected to remain a high-growth contributor through 2031.
How to Apply These Soft Tissue Repair Market Insights to Market Strategy
Stakeholders can leverage these trends by aligning portfolios with ASC-driven efficiency, minimally invasive techniques, and tissue-preserving technologies.
Investments in training, system integration, and value-based product bundles can further differentiate offerings in competitive segments like hip and ACL repair.
Tracking innovation across fixation materials and anchor systems will be key to sustaining relevance, particularly as pricing pressure limits premium differentiation in mature segments such as rotator cuff repair.
Conclusion
The U.S. orthopedic soft tissue repair market continues to expand steadily, led by rotator cuff repair, but it’s the hip arthroscopy and ACL reconstruction segments that represent the real growth engines through 2031.
Companies positioned to support outpatient efficiency and procedural standardization stand to capture the most value.
The U.S. Orthopedic Soft Tissue Repair Market Report provides detailed competitor shares, procedure forecasts, and growth trends you can act on.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
